How Has the Ketolides Market Size Evolved in Recent Years?
The ketolides market has seen considerable growth due to a variety of factors.
• Over the past few years, the market size of ketolides has consistently expanded. Its growth is predicted to progress from $3.22 billion in 2024 to $3.35 billion in 2025, following a compound annual growth rate (CAGR) of 4.1%.
Factors contributing to this historic period of growth include the rise in infectious diseases, increased usage of antibiotics, the need for potent and manageable treatment methods for infectious diseases, and government interventions.
What Are The Predictions for The Ketolides Market in the Coming Years?
The ketolides market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a steady boom is predicted for the ketolides market, with its size projected to augment to $4.04 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%.
Boosts in research and development efforts for ketolides, rising number of screening efforts for infectious disorders, increasing healthcare expenditures, and heightened cognizance of antimicrobial stewardship could be credited for the growth during the forecast period. Throughout the forecast period, innovative treatment approaches for infectious diseases, development of targeted therapies, strides in diagnosing and treating infectious diseases, and the creation of new ketolide formulas mark major trends.
Which Drivers Are Accelerating Growth In The Ketolides Market?
The rise in infectious diseases is predicted to underscore the upward trajectory of the ketolides market. Illnesses triggered by various pathogens, including bacteria, viruses, fungi, and parasites, these can transmit between individuals, causing a spectrum of symptoms and health troubles. An example of such an infectious disease is tuberculosis. Ketolides, being effective in combating infectious diseases, are being examined for their potential application in tuberculosis treatment due to their high intracellular activity. A notable instance, quoted by the UK Government website GOV.UK from February 2024, revealed a 10.7% surge in tuberculosis cases in England in 2023, a jump from 4,380 in 2022 to 4,850. As such, the uptick in infectious diseases contributes to the growth of the ketolides market. Ketolides Market Driver: The Upsurge of Chronic Sinusitis Fuels the Ascend of the Ketolides Market
What Are The Core Segments Of The Global Ketolides Market?
The ketolides market covered in this report is segmented –
1) By Drug Type: Telithromycin, Cethromycin, Solithromycin
2) By Indication: Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis
3) By Microorganism: Streptococcus Pneumoniae, Haemophilus Influenzae, Moraxella Catarrhalis, Chlamydophila Pneumoniae, Mycoplasma Pneumoniae
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Pre-Book The Ketolides Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Ketolides Industry?
Leading firms in the ketolides market are focusing their efforts on creating original drugs and treatments to maintain a competitive edge and uphold their market position. For example, in June 2023, AliquantumRx Inc., a biotechnical research firm based in the U.S, received approval from the United States Patent and Trademark Office (USPTO), a Department of Commerce agency, for its patent entitled 'salts and polymorphs of cethromycin for the treatment of bacterial and protozoan disease.' Cethromycin, a kind of ketolide antibiotic, is beneficial in treating numerous infections caused by bacteria and protozoa, including malaria, babesiosis, toxoplasmosis, diarrhea, among others. This patent will offer the company more opportunities to excel and reduce the risk associated with the commercialization of cethromycin, as it allows its use for diseases other than malaria.
Who Are the Key Players In The Ketolides Market?
Major companies operating in the ketolides market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories
• GSK PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Shionogi & Company Limited
• Dr. Reddys Laboratories Ltd.
• Taisho Pharmaceutical Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Zhejiang Yongtai Technology Co. Ltd.
• Corden Pharma GmbH
• Optimer Pharmaceuticals Inc.
• Vivimed Labs Limited
• Wockhardt Ltd.
• Advanced Life Sciences Holdings Inc.
What Are The Regional Insights Into The Ketolides Market?
North America was the largest region in the ketolides market in 2024. The regions covered in ketolides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
